Lactoferrin (LF) is a natural iron-binding protein found in milk. It exists either in an iron-free state (apo-LF) or bound to iron (holo-LF). Whether LF binds iron to facilitate its absorption and/or to sequester iron from potential enteropathogens remains uncertain. However, while LF is a promising tool for treating iron deficiency, it is sensitive to heat during food processing and to the acidic environment of the human stomach. This degradation often causes LF to lose its functional properties before it can promote iron absorption effectively. This study aims to evaluate whether encapsulating apo-LF (either alone or in combination with iron) can protect LF from digestion and enhance iron absorption. Using a randomized, crossover design, different encapsulation methods will be compared to determine which results in the highest iron absorption in women with iron deficiency. All test compounds will be labeled with stable iron isotopes. Participants will consume the labeled compounds with a test meal or water in a randomized order, allowing for within subject comparisons. Fractional iron absorption will be measured 17 days after administration via the incorporation of labeled iron into red blood cells.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
45
Maize porridge with labelled ferrous sulfate (58Fe)
Maize porridge with labelled ferrous sulfate (58Fe) and lactoferrin
Maize porridge with labelled ferrous sulfate (57Fe) and in sodium caseinate encapsulated lactoferrin
Maize porridge with sodium caseinate-lactoferrin-Fe (intrinsically labeled with iron isotope 54)
Maize porridge with labelled ferrous sulfate (54Fe) and low methoxy pectin lactoferrin
Maize porridge with low methoxy pectin-lactoferrin-Fe (intrinsically labelled with iron isotope 57)
Water with sodium caseinate-lactoferrin-Fe (intrinsically labelled with iron isotope 54Fe)
Water with low methoxy pectin-lactoferrin-Fe (intrinsically labelled with iron isotope 57Fe)
Water with ferrous sulfate (labelled with iron isotope 58Fe)
ETH Zurich, Laboratory of Clinical Biopharmacy
Zurich, Switzerland
RECRUITINGFractional iron absorption (%)
Fractional iron absorption calculated as the percentage of the administered labelled iron dose incorporated into red blood cells. The calculation is based on the measured shift in iron isotope ratios in blood samples collected 17 days after intake compared to baseline.
Time frame: Day 22
Fractional iron absorption (%)
Fractional iron absorption calculated as the percentage of the administered labelled iron dose incorporated into red blood cells. The calculation is based on the measured shift in iron isotope ratios in blood samples collected 17 days after intake compared to day 22.
Time frame: Day 43
Fractional iron absorption (%)
Fractional iron absorption calculated as the percentage of the administered labelled iron dose incorporated into red blood cells. The calculation is based on the measured shift in iron isotope ratios in blood samples collected 17 days after intake compared to day 43.
Time frame: Day 64
Hemoglobin (g/dL)
Iron status marker
Time frame: Day 1
Hemoglobin (g/dL)
Iron status marker
Time frame: Day 22
Hemoglobin (g/dL)
Iron status marker
Time frame: Day 43
Hemoglobin (g/dL)
Iron status marker
Time frame: Day 64
Serum Ferritin (µg/L)
Iron status marker
Time frame: Day 1
Serum Ferritin (µg/L)
Iron status marker
Time frame: Day 22
Serum Ferritin (µg/L)
Iron status marker
Time frame: Day 43
soluble Transferrin Receptor (mg/L)
Iron status marker
Time frame: Day 1
soluble Transferrin Receptor (mg/L)
Iron status marker
Time frame: Day 22
soluble Transferrin Receptor (mg/L)
Iron status marker
Time frame: Day 43
C-reactive protein (mg/L)
Chronic inflammation marker
Time frame: Day 1
C-reactive protein (mg/L)
Chronic inflammation marker
Time frame: Day 22
C-reactive protein (mg/L)
Chronic inflammation marker
Time frame: Day 43
Alpha-1-acid Glycoprotein (g/L)
Acute inflammation marker
Time frame: Day 1
Alpha-1-acid Glycoprotein (g/L)
Acute inflammation marker
Time frame: Day 22
Alpha-1-acid Glycoprotein (g/L)
Acute inflammation marker
Time frame: Day 43
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.